TIDE:   Tumor Immune Dysfunction and Exclusion
is a gene expression biomarker to predict the clinical response to immune checkpoint blockade.
You can download
some test samples of pre-treatment melanoma tumor expression profiles of patients. Please make sure Entrez ID or Hugo Symbols are used for human gene names. Please look at our sample gene expression files.
: This web application of TIDE is developed for research purpose. Please use it at your own risk for clinical diagnosis.
© Dana Farber Cancer Institute & Harvard University 2017